Subsequent Events (Details) - Subsequent Event - USD ($) $ in Millions |
Jun. 28, 2021 |
May 25, 2021 |
|---|---|---|
| Omni IPA Medical Group, Inc. | ||
| Subsequent Event [Line Items] | ||
| Consideration for acquisition of assets | $ 5.0 | |
| Medcore Hp [Member] | ||
| Subsequent Event [Line Items] | ||
| Consideration for acquisition of equity interests | $ 31.5 | |
| Merger agreement with Foresight Acquisition Corp | ||
| Subsequent Event [Line Items] | ||
| Estimated post-transaction enterprise value | $ 2,300.0 | |
| Merger agreement with Foresight Acquisition Corp | Minimum | ||
| Subsequent Event [Line Items] | ||
| Estimated post-transaction enterprise value | $ 2,000.0 |
| X | ||||||||||
- Definition The estimated post-transaction enterprise value. No definition available.
|
| X | ||||||||||
- Definition Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|